Updated Tuesday, November 21, 2017
 Journal Tools
RSS Feed
Sample Copy
Submit a Manuscript
Contact Us
Subscription
Advertising
Thanking Peer Reviewers
 Language Polishing
Journal of Chinese Integrative Medicine: Volume 9, 2011   Issue 7,  Pages: 702-710

DOI: 10.3736/jcim20110702
Systematic Review
A review of the use of bromelain in cardiovascular diseases
1. Chit Moy Ley (School of Psychology, Social Care and Human Sciences, University of West London, Middlesex, TW8 9GA, UK )
2. Amalia Tsiami (School of Psychology, Social Care and Human Sciences, University of West London, Middlesex, TW8 9GA, UK )
3. Qing Ni (Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
4. Nicola Robinson (Faculty of Health and Social Care, London South Bank University, London SE1 0AA, UK E-mail: robinsn4@lsbu.ac.uk)
Welcome to JIM! You are the number 25105 reader of this article!
Download Article:
[Full Text]      [PDF]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Ley CM, Tsiami A, Ni Q, Robinson N. A review of the use of bromelain in cardiovascular diseases. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2011; 9(7): 702-710.
References:
1World Health Organization. Cardiovascular diseases. (2011) [2011-02-03]. http://www.who.int/cardiovascular_diseases/en/
2World Health Organization. Cardiovascular diseases (CVDs). (2011-01) [2011-02-03]. http://www.who.int/mediacentre/factsheets/fs317/en/
3British Heart Foundation, 1999-2009: a decade of achievements. (2010) [2011-02-03]. http://publications.bhf.org.uk/about-us/who-we-are/our-history/1999-2009.aspx.
4American Heart Association. Diabetes and cardiovascular disease. (2010-09-08) [2011-02-03]. http://www.heart.org/HEARTORG/Conditions/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp.
5Jackson PPR, Aarabi M, Wallis E. Aspirin for primary prevention of coronary heart disease[J].Cochrane Database Syst Rev, 2004, (1): CD004586.  
6Lip GY, Felmeden DC. Antiplatelet agents and anticoagulants for hypertension[J].Cochrane Database Syst Rev, 2004, (3): CD003186.  
7Perez MI, Musini VM, Wright JM. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event[J].Cochrane Database Syst Rev, 2009, (4): CD006743.  
8Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S. Statins for the primary prevention of cardiovascular disease[J].Cochrane Database Syst Rev, 2011, (1): CD004816.  
9King DE, Ellis TM, Everett CJ, Mainous AG 3rd. Medication use for diabetes, hypertension, and hypercholesterolemia from 1988-1994 to 2001-2006[J].South Med J, 2009, 102(11): 1127-1132.  
10Heinicke RM, Gortner WA. Stem bromelain — a new protease preparation from pineapple plants[J].Econ Bot, 1957, 11(3): 225-234.  
11Kelly GS. Bromelain: a literature review and discussion of its therapeutic applications[J].Alt Med Rev, 1996, 1(4): 243-257.  
12Guimares-Ferreira CA, Rodrigues EG, Mortara RA, Cabral H, Serrano FA, Ribeiro-dos-Santos R, Travassos LR. Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa[J].Neoplasia, 2007, 9(9): 723-733.  
13Heinicke RM, van der Wal L, Yokoyama M. Effect of bromelain (Ananase) on human platelet aggregation[J].Experientia, 1972, 28(7): 844-845.  
14Metzig C, Grabowska E, Eckert K, Rehse K, Maurer HR. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo[J].In Vivo, 1999, 13(1): 7-12.  
15Felton GE. Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients[J].Med Hypotheses, 1980, 6(11): 1123-1133.  
16Pirotta F, De Giuli-Morghen C. Bromelain — a deeper pharmacological study. NoteⅠ. Antiinflammatory and serum fibrinolytic activity after oral administration in the rat[J].Drugs Exp Clin Res, 1978, 4: 1-20.  
17Brien S, Lewith G, Walker A, Hicks SM, Middleton D. Bromelain as a treatment for osteoarthritis: a review of clinical studies[J].Evid Based Complement Alternat Med, 2004, 1(3): 251-257.  
18Brien S, Lewith G, Walker AF, Middleton R, Prescott P, Bundy R. Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study[J].QJM, 2006, 99(12): 841-850.  
19Rosenberg L, Lapid O, Bogdanov-Berezovsky A, Glesinger R, Krieger Y, Silberstein E, Sagi A, Judkins K, Singer AJ. Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report[J].Burns, 2004, 30(8): 843-850.  
20Neumayer C, Fügl A, Nanobashvili J, Blumer R, Punz A, Gruber H, Polterauer P, Huk I. Combined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscle[J].J Surg Res, 2006, 133(2): 150-158.  
21Bahde R, Palmes D, Minin E, Stratmann U, Diller R, Haier J, Spiegel HU. Bromelain ameliorates hepatic microcirculation after warm ischemia[J].J Surg Res, 2007, 139(1): 88-96.  
22Gutfreund AE, Taussig SJ, Morris AK. Effect of oral bromelain on blood pressure and heart rate of hypertensive patients[J].Hawaii Med J, 1978, 37(5): 143-146.  
23Taussig SJ. The mechanism of the physiological action of bromelain[J].Med Hypotheses, 1980, 6(1): 99-104.  
24Tochi BN, Wang Z, Xu SY, Zhang WB. Therapeutic application of pineapple protease (bromelain): a review[J].Pakistan J Nutr, 2008, 7(4): 513-520.  
25Joanna Briggs Institute. JBI comprehensive systematic review training program: Module 3 — The appraisal, extraction and pooling of quantitative Data. 2010.
26Stevinson C, Lawlor DA. Searching multiple databases for systematic reviews: added value or diminishing returns?[J].Complement Ther Med, 2004, 12(4): 228-232.  
27Juhasz B, Thirunavukkarasu M, Pant R, Zhan L, Penumathsa SV, Secor ER Jr, Srivastava S, Raychaudhuri U, Menon VP, Otani H, Thrall RS, Maulik N. Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium[J].Am J Physiol Heart Circ Physiol, 2008, 294(3): H1365-H1370.  
28Gaciong Z, Paczek L, Bojakowski K, Socha K, Wisniewski M, Heidland A. Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model[J].Nephrol Dial Transplant, 1996, 11(6): 987-989.  
29Nieper HA. Effect of bromelain on coronary heart disease and angina pectoris[J].Acta Med Empirica, 1978, 5: 274-278.  
30Seligman B. Oral bromelains as adjuncts in the treatment of acute thrombophlebitis[J].Angiology, 1969, 20(1): 22-26.  
31Maurer HR. Bromelain: biochemistry, pharmacology and medical use[J].Cell Mol Life Sci, 2001, 58(9): 1234-1245.  
32Malezieux E. Global network for pineapple research[J].Acta Hortic, 2000, 529: 35-47.  
 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号